990 related articles for article (PubMed ID: 35251600)
1. Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report.
Alshammari F; Abuzied Y; Korairi A; Alajlan M; Alzomia M; AlSheef M
Ann Med Surg (Lond); 2022 Mar; 75():103420. PubMed ID: 35251600
[TBL] [Abstract][Full Text] [Related]
2. Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report.
Kong J; Cuevas-Castillo F; Nassar M; Lei CM; Idrees Z; Fix WC; Halverstam C; Mir A; Elbendary A; Mathew A
J Infect Public Health; 2021 Oct; 14(10):1392-1394. PubMed ID: 34294590
[TBL] [Abstract][Full Text] [Related]
3. Generalized Papulovesicular Eruption as a Side Effect of the Pfizer-BioNTech COVID-19 Vaccine.
Alamri A; Alghamdi Y; Alamri SJ; Althaqafi MK; AlQurashi W; Bader BA; Mohanna AT; Almahdi B
Cureus; 2022 Feb; 14(2):e22414. PubMed ID: 35371700
[TBL] [Abstract][Full Text] [Related]
4. A Patient Develops Bullous Rash After Receiving the Second Dose of COVID-19 Vaccine.
Nida SS; Tobon GJ; Wilson M; Chauhan K
Cureus; 2022 Sep; 14(9):e29786. PubMed ID: 36340561
[TBL] [Abstract][Full Text] [Related]
5. Bullous Pemphigoid Masquerading as Erythema Annulare Centrifugum.
Yu-Yang S; Chu-Sung Hu S; Yiao-Lin S
Acta Dermatovenerol Croat; 2017 Oct; 25(3):255-256. PubMed ID: 29252183
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
7. A new eruption of bullous pemphigoid following mRNA COVID-19 vaccination.
Daines B; Madigan LM; Vitale PA; Khalighi M; Innes M
Dermatol Online J; 2022 Aug; 28(4):. PubMed ID: 36259862
[TBL] [Abstract][Full Text] [Related]
8. Side Effects of COVID-19 Pfizer-BioNTech mRNA Vaccine in Children Aged 12-18 Years in Saudi Arabia.
Alamer E; Alhazmi A; Qasir NA; Alamer R; Areeshi H; Gohal G; Qadri M; Hashem AM; Algaissi A
Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835228
[No Abstract] [Full Text] [Related]
9. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
[TBL] [Abstract][Full Text] [Related]
10. Concomitant Severe Psoriasis and Bullous Pemphigoid Induced by COVID-19.
Martora F; Battista T; Fabbrocini G; Megna M
Trop Med Infect Dis; 2023 Feb; 8(2):. PubMed ID: 36828523
[TBL] [Abstract][Full Text] [Related]
11. An Unusual Presentation of Erythema Multiforme Following the Administration of Pfizer-BioNTech COVID-19 mRNA Vaccine in a Pediatric Patient.
Alghamdi Y; Abdulghani F; Huwait HF; Abdulghani M; Samarkandy SJ
Cureus; 2024 Apr; 16(4):e58450. PubMed ID: 38765345
[TBL] [Abstract][Full Text] [Related]
12. New-onset or flare-up of bullous pemphigoid associated with COVID-19 vaccines: a systematic review of case report and case series studies.
Ghanaatpisheh A; Safari M; Haghshenas H; Motamed-Sanaye A; Atefi AH; Kamangarpour K; Bagherzadeh MA; Kamran-Jahromi A; Darayesh M; Kouhro N; Bahadori AR; Esfandiari MA
Front Med (Lausanne); 2024; 11():1293920. PubMed ID: 38654835
[TBL] [Abstract][Full Text] [Related]
13. Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans - Five Veterans Affairs Medical Centers, United States, February 1-September 30, 2021.
Bajema KL; Dahl RM; Evener SL; Prill MM; Rodriguez-Barradas MC; Marconi VC; Beenhouwer DO; Holodniy M; Lucero-Obusan C; Brown ST; Tremarelli M; Epperson M; Mills L; Park SH; Rivera-Dominguez G; Morones RG; Ahmadi-Izadi G; Deovic R; Mendoza C; Jeong C; Schrag SJ; Meites E; Hall AJ; Kobayashi M; McMorrow M; Verani JR; Thornburg NJ; Surie D; ; ;
MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(49):1700-1705. PubMed ID: 34882654
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: A Case report of Pemphigus Vulgaris and a literature review.
Calabria E; Canfora F; Mascolo M; Varricchio S; Mignogna MD; Adamo D
Pathol Res Pract; 2022 Apr; 232():153834. PubMed ID: 35278817
[TBL] [Abstract][Full Text] [Related]
15. Suspected Anaphylactic Reaction Following Second Dose of the Pfizer-BioNTech (BNT162b2) Coronavirus Vaccine in a Geriatric Female.
Hong A; Sardinas G
HCA Healthc J Med; 2022; 3(6):349-354. PubMed ID: 37427315
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 Vaccine Safety in Children Aged 5-11 Years - United States, November 3-December 19, 2021.
Hause AM; Baggs J; Marquez P; Myers TR; Gee J; Su JR; Zhang B; Thompson D; Shimabukuro TT; Shay DK
MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(5152):1755-1760. PubMed ID: 34968370
[TBL] [Abstract][Full Text] [Related]
17. Eosinophil-rich linear IgA bullous dermatosis induced by mRNA COVID-19 booster vaccine.
Nahm WJ; Juarez M; Wu J; Kim RH
J Cutan Pathol; 2023 Jan; 50(1):24-28. PubMed ID: 35922892
[TBL] [Abstract][Full Text] [Related]
18. Safety Profile of COVID-19 Vaccines among Healthcare Workers in Poland.
Paczkowska A; Hoffmann K; Michalak M; Hans-Wytrychowska A; Bryl W; Kopciuch D; Zaprutko T; Ratajczak P; Nowakowska E; Kus K
Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335066
[TBL] [Abstract][Full Text] [Related]
19. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination.
Larson V; Seidenberg R; Caplan A; Brinster NK; Meehan SA; Kim RH
J Cutan Pathol; 2022 Jan; 49(1):34-41. PubMed ID: 34292611
[TBL] [Abstract][Full Text] [Related]
20. Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series.
Johnston MS; Galan A; Watsky KL; Little AJ
JAMA Dermatol; 2021 Jun; 157(6):716-720. PubMed ID: 33978670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
